← Back to headlines
Hims Shares Jump on Deal to Offer Novo's Weight-Loss Drugs
Hims & Hers Health shares surged following a deal to offer Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, on its platform.
9 Mar, 10:33 — 9 Mar, 21:08
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center1
Center (1)
Reuters
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 2 regions9/34
US1Intl1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
ReutersVery High14h ago
Hims shares jump on deal to offer Novo's Wegovy, Ozempic on its platform - Reuters
Hims shares jump on deal to offer Novo's Wegovy, Ozempic on its platform Reuters
Read full article →seeking-alphaMixed4h ago
Hims & Hers Health boosted at Citi on Novo Nordisk partnership
Read full article →Coverage Timeline
First report: Reuters · 9 Mar, 10:33|Full coverage: All 2 sources within 11h|Window: 11h
Left-leaningCenterRight-leaning
